Dr. Andy Galpin

So we'll see this in gait before we'll see this in symptoms.

Companies that are involved in this entire thing, we can take all those data, we're actually doing this right now, put them together and make what's called a digital twin.

This allows us to make your physiology.

And so from our perspective of vitality, we've got all your blood work and molecular biomarkers.

For the rest, we've got your sleep.

We've got your movement patterns.

We can actually work with another company to watch you physically move and do that stuff.

We can take your physiology and upload it.

Then from there, we can run endless simulations of combinations of nutrition and training and supplementation

medicine, movement, daytime patterns, sunlight, water, all those things, and figure out really quickly how you're going to respond the best for whatever outcome we want.

It's not ready at all right now.

But we're actually, again, running it right now.

We'll have our first cohort done probably in the next week or so.

Yeah, really, really soon.

I don't know how well the model is going to be the first time through it.

I don't know if our group's going to be the best at it.

It doesn't matter.

But this is clearly going to be something the world is capable of.

As we get better at being human sensors and we can bring those data in, we're going to be able to deploy things like this and say, hey, yo, this is most likely to work for you.

The digital twin is already being used for like the heart, right?